Navigation Links
Bioniche Reports Fiscal 2008 Second Quarter
Date:2/8/2008

months ended December 31

Current Last Year Current Last

Quarter Quarter Year to Date Year to Date

2007 2006 2007 2006

$ $ $ $

-------------------------------------------------------------------------

OPERATING

ACTIVITIES

Net loss for the

period (4,217,165) (2,913,071) (8,029,923) (5,653,935)

Add (deduct)

non-cash items:

Amortization 614,146 1,144,622 1,145,228 1,828,363

Accreted interest

on convertible

term note - 510,587 - 619,413

Change in unrealized

loss (gain) on

foreign currency

embedded

derivatives 44,453 - (138,203) -

Foreign exchange

loss (gain) 21,667 351,777 (53,451) 345,644

Stock-based

compensation 94,228 55,242 178,974 111,022

Share compensation 253,437 81,000 253,437 81,000

Employee share

ownership plan 163,553 212,662 311,322 212,662

Impairment of

investment - - - 175,000

Loss on sale of

investment - 17,157 - 17,157

Gain on sale of

right to future

royalty stream - (2,127,587) - (2,127,587)

-------------------------------------------------------------------------

(3,025,681) (2,667,611) (6,332,616) (4,391,261)

Net change in

non-cash working

capital balances (1,475,702) 792,819 (830,764) 1,097,708

-------
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2008)...c Gamma Imaging (BSGI) is,shown to be an effectiv...cally,occult (hidden) breast cancer. BSGI is a mo...ions independent of tissue density and discover ve...sented today at the annual meeting of,the Radiolo...y of women where,breast cancer was already suspec...
(Date:12/3/2008)...rovide health benefits , , CHICAGO, Dec. 3 ... soft drink is 20 ounces and contains 17 teaspoons...s found in fruit drinks are more erosive than hydr...s battery acid. These refined sugars and acids fou... which wears away the hard part of the teeth, or t...
(Date:12/3/2008)...on, mental health 15 years later , , WED...ook part in a social development program in elemen...lth, and educational and economic success as young...teen pregnancy, school dropouts and mental health ...ildren and families who live in cities, noted stud...
(Date:12/3/2008)...s of blood clots, researchers at the University of...enzyme that not only affects the blood, but seems ... and spread throughout the body. The research appe...he Journal of Thrombosis and Haemostasis . , A...iscovered the enzyme called sFAP in plasma. After ...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Identifies Occult Cancer 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 3Health News:School-Based Program Can Change Kids' Lives 2Health News:Researchers discover new enzyme in cancer growth 2
...hers at Vanderbilt University Medical Center revea...They report that the Golgi apparatus -- a stack o... proteins out to their cellular destinations -- is...f these microscopic fibers. Scientists have long ...
...eating disorder figures among seem to soar out of ...atistics published in response to parliamentary qu...number of children being hospitalized with eating ...e last decade. This mainly comprises of people und...
... patients and women seeking surgical procedures am...hair restoration procedures were performed worldwi... statistics released today from a recent member su...ir Restoration Surgery (ISHRS) -- the world's lead...
...tish government took a step Wednesday toward offer... as young as 12, a measure that could be carried ...cination and Immunisation (JCVI) recommended the u...oma virus (HPV), a sexually transmitted infection ...
Other Medicine News:Health News:Research in the Origin of Microtubules 2Health News:Research in the Origin of Microtubules 3Health News:Eating Disorder Figures Among Children Soars 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 2Health News:Hair Restoration Procedures Performed Worldwide Increased 34 Percent in 2006 3Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2
(Date:12/2/2008)...BRIDGE, Mass., Dec. 2 Bi...ay that the U.S. Naval Medical Research Center,(N...tion (FDA) a revised,investigational new drug (IN...,company,s oxygen therapeutic Hemopure(R) [hemoglo... battlefield treatment of trauma patients. The stu...
(Date:12/1/2008)...CAGO, Dec. 2 New resear...ight-slice computed tomography (CT) scanner in an ...er of stroke victims who receive a potentially lif...d at North Shore Medical Center (NSMC)-Salem Hospi...e annual meeting of the Radiological Society of No...
(Date:12/1/2008)...IANAPOLIS, Dec. 1 Roche announced ...ate differences in perceived pain and,discomfort ...CHEK blood,glucose monitoring systems and lancing...ts indicated that, overall, the ACCU-CHEK Aviva an... systems and the ACCU-CHEK Multiclix, ACCU-CHEK,S...
(Date:12/1/2008)... KVISTGARD, Denmark, December 1 /PRNewswire-FirstC...n 2007 with the intent to procure an MVA-based,t... Government Services,Canada, on behalf of the Can...,a contract to Bavarian Nordic for the delivery of...tend to use IMVAMUNE(R) as part of the,country,s ...
Breaking Medicine Technology:U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Therapy Could Save Limbs After Frostbite 14493 1Therapy Could Save Limbs After Frostbite 14493 2A Journal for Karen 3A Author Shares Gift of Love for Sister with Readers Everywhere Touched by Cancer 14490 1A Journal for Karen 3A Author Shares Gift of Love for Sister with Readers Everywhere Touched by Cancer 14490 2Conseco Declines Partnerships Request for Board Seats 3B Review of Strategic Alternatives Underway 14487 1Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets 4006 1Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets 4006 2Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets 4006 3
...be Presented April 15th at EASL Conference in Barc...1, 2007,/PRNewswire-FirstCall/ - MIGENIX Inc. , a ...iseases, has received new top-line results,confirm...ember 6,2006) indicating evidence of clinical ben...using the oral alpha-glucosidase,inhibitor, celgos...
...E, Mass.--(BUSINESS WIRE)--Apr 11, 2007 - Gloucest...harmaceutical,company, announced today that severa...sin will be presented at the 2007,Annual Meeting o...ng place in Los Angeles, CA April 14-18, 2007. The...nical research,performed by multiple academic coll...
Other Medicine Technology:New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 2Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 3
Volk's super series slit lamp biomicroscopy lenses. General retinal scanning & small pupil exams. Provide unprecedented fundus diagnostic capability, specifically addressing maximum potential field o
Volk indirect lenses. General diagnosis / small pupil examinations.
This contact class is particularly suitable for use with slit lamps which have a smaller distance between the eye and the reduction prism than the Haag-Streit 900, mirror: 3, area: fundus / iridocorn
...e standard for steam Sterilization. The Tuttnauer ...lthcare and laboratory facility. Our basic manual ...eeds. Time tested reliability and durability are b... Series is also available in a quick cycle model, ...
Medicine Products: